These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9241361)
21. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)]. Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188 [TBL] [Abstract][Full Text] [Related]
22. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
23. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Yamabuki T; Takano A; Hayama S; Ishikawa N; Kato T; Miyamoto M; Ito T; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Kondo S; Nakamura Y; Daigo Y Cancer Res; 2007 Mar; 67(6):2517-25. PubMed ID: 17363569 [TBL] [Abstract][Full Text] [Related]
24. Elevated serum arginase activity levels in patients with breast cancer. Polat MF; Taysi S; Polat S; Böyük A; Bakan E Surg Today; 2003; 33(9):655-61. PubMed ID: 12928840 [TBL] [Abstract][Full Text] [Related]
25. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Gordon SG; Mielicki WP Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049 [TBL] [Abstract][Full Text] [Related]
26. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Kopreski MS; Benko FA; Gocke CD Ann N Y Acad Sci; 2001 Sep; 945():172-8. PubMed ID: 11708475 [TBL] [Abstract][Full Text] [Related]
27. Increased plasma free tryptophan levels in human cancer: a tumor related effect? Cascino A; Cangiano C; Ceci F; Franchi F; Mineo T; Mulieri M; Muscaritoli M; Rossi Fanelli F Anticancer Res; 1991; 11(3):1313-6. PubMed ID: 1888165 [TBL] [Abstract][Full Text] [Related]
28. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
29. Application of cancer procoagulant as an early detection tumor marker. Kozwich DL; Kramer LC; Mielicki WP; Fotopoulos SS; Gordon SG Cancer; 1994 Aug; 74(4):1367-76. PubMed ID: 8055461 [TBL] [Abstract][Full Text] [Related]
30. Cancer procoagulant in human tumor cells: evidence from melanoma patients. Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081 [TBL] [Abstract][Full Text] [Related]
31. Monocyte tissue factor levels in cancer patients. Lwaleed BA; Francis JL; Chisholm M Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of diagnostic values of neoplastic procoagulant in pancreatic, hepatic and ovary cancers]. Snarska J; Szajda S; Skrzydlewski Z; Kozuszko B Pol Merkur Lekarski; 2003 Aug; 15(86):123-4. PubMed ID: 14648973 [TBL] [Abstract][Full Text] [Related]
33. Cancer procoagulant--CP. Rucińska M; Gacko M; Skrzydlewski Z Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529 [TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of testing the procoagulant activity of neoplasms in cases of stomach and esophageal neoplasms]. Kozuszko B; Skrzydlewski Z; Kozłowski M; Snarska J Pol Merkur Lekarski; 2001 Mar; 10(57):143-4. PubMed ID: 11398511 [TBL] [Abstract][Full Text] [Related]
35. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A; Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304 [TBL] [Abstract][Full Text] [Related]
36. [Serum markers in breast cancer and colorectal cancer (1997)]. Bellet D; Mlika-Cabanne N; Bedenne L; Brun B; Demeaux JL; Legrand JL; Lorimier G; Mignotte H; Ollivier JM; Piperno-Neumann S; Rinaldi Y; Rousset H; Rymer JC; Laversin S Gynecol Obstet Fertil; 2001 Jan; 29(1):62-3. PubMed ID: 11217195 [No Abstract] [Full Text] [Related]
37. Procoagulant factors in patients with cancer. Molnar S; Guglielmone H; Lavarda M; Rizzi ML; Jarchum G Hematology; 2007 Dec; 12(6):555-9. PubMed ID: 17852460 [TBL] [Abstract][Full Text] [Related]
38. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628 [TBL] [Abstract][Full Text] [Related]
39. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
40. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. Kumar H; Heer K; Greenman J; Kerin MJ; Monson JR Anticancer Res; 2002; 22(3):1877-80. PubMed ID: 12168886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]